salmeterol xinafoate has been researched along with Cardiomegaly in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lynch, GS; Ryall, JG; Sillence, MN | 1 |
1 other study(ies) available for salmeterol xinafoate and Cardiomegaly
Article | Year |
---|---|
Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Down-Regulation; Ethanolamines; Formoterol Fumarate; Heart; Male; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Myocardium; Rats; Rats, Inbred F344; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate | 2006 |